Treatment
SHR-1819 clinical trials
We’re tracking 4 recruiting studies that include SHR-1819, each written for real people, not researchers, below.
Recruiting studies
- NCT07688772RecruitingPhase 3
Study of SHR-1819 Injection for Seasonal Allergic Rhinitis
This trial tests a new injection called SHR-1819 for people with seasonal allergies who haven't responded well to standard treatments like nasal sprays or antihistamines. It aims to see if it can reduce allergy symptoms.
Beijing, Beijing MunicipalityAges 18–75 - NCT06554509RecruitingPhase 2/Phase 3
Study of SHR-1819 for prurigo nodularis
This trial tests an injection called SHR-1819 for adults with prurigo nodularis, a skin condition with itchy bumps. The goal is to see if it helps reduce itching and bumps.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07309055RecruitingPhase 3
Study of SHR-1819 injection for teens with severe eczema
This trial tests an injectable medicine called SHR-1819 for teenagers aged 12 to 17 with severe atopic dermatitis (eczema) that has not responded well to creams or other treatments. The goal is to see if it can improve skin symptoms and reduce itching.
Shenyang, LiaoningAges 12–17 - NCT07091357RecruitingPhase 2
Study of SHR-1819 for seasonal allergies
This trial tests an injection called SHR-1819 for people with seasonal allergic rhinitis (hay fever) that isn't well controlled by standard treatments like nasal sprays or antihistamines. The goal is to see if it helps reduce allergy symptoms during pollen season.
Beijing, Beijing MunicipalityAges 18–75
What SHR-1819 is being studied for
Conditions with recruiting SHR-1819 studies.
Common questions
- Are there clinical trials studying SHR-1819?
- Yes. Clin2 currently lists 4 recruiting studies that include SHR-1819, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a SHR-1819 trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is SHR-1819 an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether SHR-1819 or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.